Pegfilgrastim Biosimilars Amid Increasing Leukaemia Cases: Market Trends and Outlook 2024-2032
Pegfilgrastim is a long-acting version of filgrastim, a granulocyte colony-stimulating factor (G-CSF) that plays a crucial role in reducing the risk of infection in patients undergoing chemotherapy. Pegfilgrastim biosimilars replicate…